Top 10 Oncology Capital Raises in the U.S. – September 16th-30th, 2024
Several interesting transactions closed in the Oncology over the past 2 weeks. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
Merger/Acquisition and Corporate
- Doherty Dermatology, a dermatology-focused cancer treatment provider, was acquired by Frontier Dermatology through an LBO backed by A&M Capital.
- IMD, a provider of medical imaging solutions, was acquired by LabGenomics.
- G1 Therapeutics, a developer of cancer therapies, was acquired by Pharmacosmos for $282.33 million.
Later Stage VC
- 858 Therapeutics, a biotech company focused on cancer therapies, raised $50 million funding led by Avidity Partners. The funds will support clinical development of its small molecule therapeutics.
- VieCure, a personalized oncology platform, raised $45 million of venture funding from Northpond Ventures to scale commercial operations and meet growing demand.
- Convergent Therapeutics, a radiopharmaceutical company, raised $40 million venture funding from Novo Holdings to support its radiopharmaceutical pipeline.
- CTRL Therapeutics, an oncology biotech company, raised $9.14 million of venture funding.
Early Stage VC
- Aktis Oncology, a radiopharmaceutical company, raised $175 million funding led by RA Capital Management, RTW Investments, and Janus Henderson Investors. The funds will be used to advance the company’s radiopharmaceutical pipeline.
- VerImmune, a cancer immunotherapy developer, raised $4.5 million funding led by Bailey Biofund. The funds will be used to advance the company’s lead product candidate towards clinical trials.
Seed Round, Angel and Grant
- Nucs Ai, an AI-powered oncology platform, raised $3.5 million of seed funding to support its development of cancer treatment technologies.
#castleplacement #capitalraising #privateequity #venturecapital #oncology #biotech #investment
Gary Levy
Managing Director
Over 30 years in financial services, including senior roles at Citi, Ivy Asset Management (an Affiliate of BNY) and TIAA. Founder and President of Biltmore Savings Consultants, a provider of B2B technology solutions to improve operations. Author of published book "21 Ways to Improve Your Business Operations." MBA - Strategic Business Management from Hofstra University’s Frank G. Zarb School of Business. BS (with a concentration in Business, Management and Economics) from SUNY Empire State College. Series 7, 63 and 79 licenses.
- Email: glevy@castleplacement.com
- (C) (516) 457-0104
 Gary LevyManaging Director |
Please contact me if you have any questions or would like to discuss your capital raise:
Email: glevy@castleplacement.com
(C) (516) 457-0104
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement™ does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
